BiOptic
TWSE:6850Taipei, Taiwan· Est.
BiOptic delivers cost‑effective capillary electrophoresis and PCR solutions for genomics and clinical diagnostics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
BiOptic delivers cost‑effective capillary electrophoresis and PCR solutions for genomics and clinical diagnostics.
Molecular DiagnosticsGenomicsGlycoscienceLife Sciences
Technology Platform
Capillary gel electrophoresis (CGE) with disposable pen‑shaped gel cartridges, integrated with automated PCR amplification for high‑resolution fragment analysis.
Opportunities
Growing demand for rapid, multiplexed molecular diagnostics and glycan profiling creates expansion opportunities for BiOptic’s integrated PCR‑CE platforms in clinical and research markets.
Risk Factors
Regulatory approval timelines, competition from larger instrument manufacturers, and reliance on global supply chains could constrain market penetration.
Competitive Landscape
BiOptic competes with established CE and PCR instrument makers such as Bio‑Rad, Agilent, and Thermo Fisher, differentiating through disposable cartridge technology, lower cost, and integrated workflow solutions.